Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection

Parasite Immunology

Volumn 34, Issue 8-9, 2012, Pages 412-420

  Zhu, X ^a   Pan, Y ^a   Li, Y ^a   Cui, L ^b   Cao, Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Activation; Arginine; Dendritic cell; Immune response; Plasmodium yoelii; Rodent malaria

Indexed keywords

ARGININE; CD36 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NITRIC OXIDE; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DISEASE MODEL; ENDEMIC DISEASE; FEMALE; IMMUNE RESPONSE; IMMUNITY; MACROPHAGE; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PARASITEMIA; PLASMACYTOID DENDRITIC CELL; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPLEEN CELL; STAGING; SURVIVAL TIME; UPREGULATION;

ANIMALS; ARGININE; CD4-POSITIVE T-LYMPHOCYTES; DIET; DIETARY SUPPLEMENTS; FEMALE; INTERFERON-GAMMA; MACROPHAGES; MALARIA; MICE; MICE, INBRED BALB C; PARASITEMIA; PLASMODIUM YOELII; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS;

MUS; PLASMODIUM YOELII; RODENTIA;

EID: 84864764068     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01374.x     Document Type: Article

References (52)

1. WHO. World Malaria Report. Available at: http://wwwwhoint/malaria/world_malaria_report_2010/en/indexhtml 2010.
2. John CC, Kutamba E, Mugarura K & Opoka RO. Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther 2010; 8: 997-1008.
3. Weinberg JB, Lopansri BK, Mwaikambo E & Granger DL. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis 2008; 21: 468-475.
4. Omodeo-Sale F, Cortelezzi L, Vommaro Z, Scaccabarozzi D & Dondorp AM. Dysregulation of L-arginine metabolism and bioavailability associated to free plasma heme. Am J Physiol Cell Physiol 2010; 299: C148-C154.
5. Boger RH & Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; 41: 79-99.
6. Yeo TW, Lampah DA, Gitawati R, et al. Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 2007; 204: 2693-2704.
7. Yeo TW, Lampah DA, Gitawati R, et al. Safety profile of L-arginine infusion in moderately severe falciparum malaria. PLoS One 2008; 3: e2347.
8. Peranzoni E, Marigo I, Dolcetti L, et al. Role of arginine metabolism in immunity and immunopathology. Immunobiology 2007; 212: 795-812.
9. Malhotra I, Mungai P, Muchiri E, et al. Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 2005; 73: 3462-3470.
10. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S & Liew FY. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993; 260: 1931-1934.
11. Othoro C, Moore JM, Wannemuehler KA, et al. Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy. Infect Immun 2008; 76: 1678-1685.
12. Stevenson MM & Riley EM. Innate immunity to malaria. Nat Rev 2004; 4: 169-180.
13. Good MF, Xu H, Wykes M & Engwerda CR. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005; 23: 69-99.
14. Wu X, Gowda NM, Kumar S & Gowda DC. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 2010; 184: 4338-4348.
15. Gowda NM, Wu X & Gowda DC. The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One 2011; 6: e20398.
16. Vigario AM, Gorgette O, Dujardin HC, et al. Regulatory CD4+ CD25+ Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int J Parasitol 2007; 37: 963-973.
17. Wu Y, Wang QH, Zheng L, et al. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Exp Parasitol 2007; 115: 301-304.
18. Bueno LL, Morais CG, Araujo FF, et al. Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One 2010; 5: e9623.
19. Bronte V & Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005; 5: 641-654.
20. Sharma KK, Mediratta PK, Reeta KH & Mahajan P. Effect of L-arginine on restraint stress induced modulation of immune responses in rats and mice. Pharmacol Res 2004; 49: 455-460.
21. Rodriguez PC, Zea AH, DeSalvo J, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (Baltimore, Md: 1950) 2003; 171: 1232-1239.
22. Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB & Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 2002; 277: 21123-21129.
23. Munder M, Schneider H, Luckner C, et al. Suppression of T-cell functions by human granulocyte arginase. Blood 2006; 108: 1627-1634.
24. Rodriguez PC, Quiceno DG & Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007; 109: 1568-1573.
25. Munder M, Choi BS, Rogers M & Kropf P. L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur J Immunol 2009; 39: 2161-2172.
26. Slade SJ & Langhorne J. Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 1989; 179: 353-365.
27. Cao YM, Tsuboi T & Torii M. Nitric oxide inhibits the development of Plasmodium yoelii gametocytes into gametes. Parasitol Int 1998; 47: 157-166.
28. Wang QH, Liu YJ, Liu J, et al. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice. Exp Parasitol 2009; 121: 268-273.
29. Langhorne J, Albano FR, Hensmann M, et al. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. Immunol Rev 2004; 201: 35-47.
30. Singh RP, Kashiwamura S, Rao P, Okamura H, Mukherjee A & Chauhan VS. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA. J Immunol 2002; 168: 4674-4681.
31. Shear HL, Srinivasan R, Nolan T & Ng C. Role of IFN-gamma in lethal and nonlethal malaria in susceptible and resistant murine hosts. J Immunol 1989; 143: 2038-2044.
32. Su Z & Stevenson MM. Central role of endogenous gamma interferon in protective immunity against blood-stage Plasmodium chabaudi AS infection. Infect Immun 2000; 68: 4399-4406.
33. Zheng W, Wang QH, Feng H, Liu J, Meng HR & Cao YM. CD4+CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. Folia Parasitol (Praha) 2009; 56: 242-250.
34. Kropf P, Baud D, Marshall SE, et al. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 2007; 37: 935-945.
35. Zea AH, Rodriguez PC, Atkins MB, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005; 65: 3044-3048.
36. Zea AH, Rodriguez PC, Culotta KS, et al. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol 2004; 232: 21-31.
37. Choi BS, Martinez-Falero IC, Corset C, et al. Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages. J Leukoc Biol 2009; 85: 268-277.
38. Stevenson MM, Huang DY, Podoba JE & Nowotarski ME. Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice. Infect Immun 1992; 60: 1193-1201.
39. Couper KN, Blount DG, Hafalla JC, van Rooijen N, de Souza JB & Riley EM. Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia. Infect Immun 2007; 75: 5806-5818.
40. Cunha-Rodrigues M, Portugal S, Febbraio M & Mota MM. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection. Malar J 2007; 6: 32.
41. Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
42. Ing R & Stevenson MM. Dendritic cell and NK cell reciprocal cross talk promotes gamma interferon-dependent immunity to blood-stage Plasmodium chabaudi AS infection in mice. Infect Immun 2009; 77: 770-782.
43. Wykes MN, Liu XQ, Beattie L, et al. Plasmodium strain determines dendritic cell function essential for survival from malaria. PLoS Pathog 2007; 3: e96.
44. Shortman K & Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
45. Gilliet M, Boonstra A, Paturel C, et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 2002; 195: 953-958.
46. Jangpatarapongsa K, Chootong P, Sattabongkot J, et al. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 2008; 38: 2697-2705.
47. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 2002; 63: 1156-1163.
48. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106: 259-262.
49. Trinchieri G & Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179-190.
50. Guermonprez P, Valladeau J, Zitvogel L, Thery C & Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002; 20: 621-667.
51. Feng H, Zhu X, Qi Z, et al. Transient attenuated Foxp3 expression on CD4(+) T cells treated with 7D4 mAb contributes to the control of parasite burden in DBA/2 mice infected with lethal Plasmodium chabaudi chabaudi AS. Scand J Immunol 2012; 75: 46-53.
52. Hisaeda H, Tetsutani K, Imai T, et al. Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol 2008; 180: 2496-2503.